Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'
Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Mike Hsu
since
auto-detected in 1 stories
35 days ago
page 1 of 1